The Effect of Rosmarinic Acid on Immunological and Neurological Systems
Tal Friedman, ND


Alzheimer’s disease
Rosmarinic acid


Rosmarinic acid (RosA) is an ester of caffeic acid and 3,4-dihydroxyphenylactic acid. RosA has a number of beneficial biological activities, including antiviral, antibacterial, anti-inflammatory, and antioxidant properties. Oxidative stress is recognized as a common factor in many neurodegenerative diseases and is a proposed mechanism for age-related degenerative processes as a whole. RosA has shown antioxidative action, acting as a scavenger of free radicals. RosA protects neurons from oxidative stress, significantly attenuated hydrogen peroxide-induced reactive oxygen species generation, and apoptotic cell death and could contribute at least in part to neuroprotective effects. RosA has also been shown to suppress immunoglobulin responses and inflammatory responses of polymorphonuclear leukocytes which may explain its effectiveness at treating seasonal allergic rhinoconjuctivitis in human clinical trials. The anti-inflammatory effects of RosA along with its immunomodulatory effects may also make it a novel agent for the treatment of auto-immune disorders. This review is focused on the effect of RosA on both immunological and neurological systems and its potential as a novel therapeutic agent for the treatment of associated conditions, especially those in which oxidative stress is a factor.



Petersen M, Simmonds M. Rosmarinic acid. Phytochemistry. 2003; 62(2):121–125.
Hajimehdipoor H, Saeidnia S, Gohari A, Hamedani M, Shekarchi M. Comparative study of rosmarinic acid content in some plants of Labiatae family. Pharmacognosy Magazine. 2012; 8(29):37.
Yarnell E, Abascal K. Botanical medicine for thyroid regulation. Altern Comp Ther. 2006; 12(3):107–112.
Bhatt R, Mishra N, Bansal PK. Phytochemical, pharmacological and pharmacokinetics effects of rosmarinic acid. J Pharmaceut Sci Innov. 2013; 2(2):28–34.
Baba S, Osakabe N, Natsume M, et al. Absorption, metabolism, degradation and urinary excretion of rosmarinic acid after intake of Perilla frutescens extract in humans. Eur J Nutr. 2005; 44(1):1–9.
Ritschel WA, Starzacher A, Sabouni A, Hussain AS, Koch HP. Percutaneous absorption of rosmarinic acid in the rat. Methods Find Exp Clin Pharmacol. 1989; 11(5):345–352.
Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008; 454(7203):428–435.
Rampart M, Beetens JR, Bult H, Herman AG, Parnham MJ, Winkelmann J. Complement-dependent stimulation of prostacyclin biosynthesis: inhibition by rosmarinic acid. Biochem Pharmacol. 1986; 35(8):1397–1400.
Englberger W, Hadding U, Etschenberg E, et al. Rosmarinic acid: A new inhibitor of complement C3-convertase with anti-inflammatory activity. Int J Immunopharmacol. 1988; 10(6):729–737.
Sahu A, Rawal N, Pangburn MK. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b. Biochem Pharmacol. 1999; 57(12):1439–1446.
Swarup V, Ghosh J, Ghosh S, Saxena A, Basu A. Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Antimicrob Agents Chemother. 2007; 51(9):3367–3370.
Kang M-A. Rosmarinic acid inhibits Ca2+-dependent pathways of T-cell antigen receptor-mediated signaling by inhibiting the PLC-gamma 1 and Itk activity. Blood. 2003; 101(9):3534–3542.
Kim HK, Lee JJ, Lee JS, Park YM, Yoon TR. Rosmarinic acid down-regulates the LPS-induced production of monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha (MIP-1alpha) via the MAPK pathway in bone-marrow derived dendritic cells. Mol Cells. 2008;31; 26(6):583–589.
Rathmell JC, Thompson CB. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell. 2002; 109(2):97–107.
Genestier L, Paillot R, Fournel S, Ferraro C, Miossec P, Revillard JP. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest. 1998; 102(2):322–328.
Rodenburg RJT, Ganga A, Van Lent PLEM, Van De Putte LBA, Van Venrooij WJ. The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor α expression in macrophages by inducing apoptosis. Arthritis Rheum. 2000; 43(9):1941–1950.
Hur Y-G, Yun Y, Won J. rosmarinic acid induces p56lck-dependent apoptosis in Jurkat and peripheral T cells via mitochondrial pathway independent from Fas/Fas ligand interaction. J Immunol. 2003; 172(1):79–87.
Hur Y-G, Suh C-H, Kim S, Won J. Rosmarinic Acid Induces Apoptosis of Activated T cells from rheumatoid arthritis patients via mitochondrial pathway. J Clin Immunol. 2007; 27(1):36–45.
Youn J, Lee KH, Won J, et al. Beneficial effects of rosmarinic acid on suppression of collagen induced arthritis. J Rheumatol. 2003; 30(6):1203–1207.
Fukui N, Honda K, Ito E, Ishikawa K. Peroxisome proliferator-activated receptor γ negatively regulates allergic rhinitis in mice. Allergol Int. 2009; 58(2):247–253.
Fuentes-Beltrán A, Montes-Vizuet R, Valencia-Maqueda E, Negrete-García MC, de L. García-Cruz M, Teran LM. Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients. Clin Exp Allergy. 2009; 39(4):491–499.
Sanbongi C, Takano H, Osakabe N, et al. Rosmarinic acid in perilla extract inhibits allergic inflammation induced by mite allergen, in a mouse model. Clin Exp Allergy. 2004; 34(6):971–977.
Oh H-A, Park C-S, Ahn H-J, Park YS, Kim H-M. Effect of Perilla frutescens var. acuta Kudo and rosmarinic acid on allergic inflammatory reactions. Exp Biol Med. 2011; 236(1):99–106.
Takano H, Osakabe N, Sanbongi C, et al. Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, inhibits seasonal allergic rhinoconjunctivitis in humans. Exp Biol Med. 2004; 229(3):247–254.
Kelsey NA, Wilkins HM, Linseman DA. Nutraceutical antioxidants as novel neuroprotective agents. Molecules. 2010; 15(11):7792–7814.
Lee HJ, Cho H-S, Park E, et al. Rosmarinic acid protects human dopaminergic neuronal cells against hydrogen peroxide-induced apoptosis. Toxicology. 2008; 250(2–3):109–115.
Fallarini S, Miglio G, Paoletti T, et al. Clovamide and rosmarinic acid induce neuroprotective effects in in vitro models of neuronal death. Br J Pharmacol. 2009; 157(6):1072–1084.
Shimojo Y, Kosaka K, Noda Y, Shimizu T, Shirasawa T. Effect of rosmarinic acid in motor dysfunction and life span in a mouse model of familial amyotrophic lateral sclerosis. J Neurosci Res. 2010; 88(4):896–904.
Park DH, Park SJ, Kim JM, Jung WY, Ryu JH. Subchronic administration of rosmarinic acid, a natural prolyl oligopeptidase inhibitor, enhances cognitive performances. Fitoterapia. 2010; 81(6):644–648.
Calabrese EJ. Alzheimer’s disease drugs: an application of the hermetic dose–response model. Crit Rev Toxicol. 2008; 38:419–451.
Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease. Lancet. 2006; 368(9533):387–403.
Falé PL, Borges C, Madeira PAJ, et al. Rosmarinic acid, scutellarein 4′-methyl ether 7-O-glucuronide and (16S)-coleon E are the main compounds responsible for the antiacetylcholinesterase and antioxidant activity in herbal tea of Plectranthus barbatus (‘falso boldo’). Food Chem. 2009; 114(3):798–805.
Falé PLV, Madeira PAJ, Florêncio HM, Ascensão L, Serralheiro MLM. Function of Plectranthus barbatus herbal tea as neuronal acetylcholinesterase inhibitor. Food Funct. 2011; 2(2):130–136.
Ono K, Hamaguchi T, Naiki H, Yamada M. Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimer’s disease. Biochim Biophys Acta. 2006; 1762(6):575–586.
Alkam T, Nitta A, Mizoguchi H, Itoh A, Nabeshima T. A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Aβ25–35. Behav Brain Res. 2007; 180(2):139–145.
Domitrović R, Škoda M, Vasiljev Marchesi V, Cvijanović O, Pernjak Pugel E, Štefan M. Rosmarinic acid ameliorates acute liver damage and fibrogenesis in carbon tetrachloride-intoxicated mice. Food Chem Toxicol. 2013; 51:370–378.
Noguchi-Shinohara M, Ono K, Hamaguchi T, et al. Pharmacokinetics, safety and tolerability of Melissa officinalis extract which contained rosmarinic acid in healthy individuals: a randomized controlled trial. PLoS ONE. 2015; 10(5):e0126422.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.